165 related articles for article (PubMed ID: 23612909)
1. Apolipoprotein E levels in the cerebrospinal fluid of north Indian patients with Alzheimer's disease.
Kandimalla RJ; Wani WY; Anand R; Kaushal A; Prabhakar S; Grover VK; Bharadwaj N; Jain K; Gill KD
Am J Alzheimers Dis Other Demen; 2013 May; 28(3):258-62. PubMed ID: 23612909
[TBL] [Abstract][Full Text] [Related]
2. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
4. Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study.
Saddiki H; Fayosse A; Cognat E; Sabia S; Engelborghs S; Wallon D; Alexopoulos P; Blennow K; Zetterberg H; Parnetti L; Zerr I; Hermann P; Gabelle A; Boada M; Orellana A; de Rojas I; Lilamand M; Bjerke M; Van Broeckhoven C; Farotti L; Salvadori N; Diehl-Schmid J; Grimmer T; Hourregue C; Dugravot A; Nicolas G; Laplanche JL; Lehmann S; Bouaziz-Amar E; ; Hugon J; Tzourio C; Singh-Manoux A; Paquet C; Dumurgier J
PLoS Med; 2020 Aug; 17(8):e1003289. PubMed ID: 32817639
[TBL] [Abstract][Full Text] [Related]
5. Influence of APOE Genotype on Alzheimer's Disease CSF Biomarkers in a Spanish Population.
Monge-Argilés JA; Gasparini-Berenguer R; Gutierrez-Agulló M; Muñoz-Ruiz C; Sánchez-Payá J; Leiva-Santana C
Biomed Res Int; 2016; 2016():1390620. PubMed ID: 27092308
[TBL] [Abstract][Full Text] [Related]
6. Plasma apolipoprotein E levels in longitudinally followed patients with mild cognitive impairment and Alzheimer's disease.
Giannisis A; Al-Grety A; Carlsson H; Patra K; Twohig D; Sando SB; Lauridsen C; Berge G; Grøntvedt GR; Bråthen G; White LR; Kultima K; Nielsen HM
Alzheimers Res Ther; 2022 Aug; 14(1):115. PubMed ID: 36002891
[TBL] [Abstract][Full Text] [Related]
7. Age-dependent decline in the apolipoprotein E level in cerebrospinal fluid from control subjects and its increase in cerebrospinal fluid from patients with Alzheimer's disease.
Fukuyama R; Mizuno T; Mori S; Yanagisawa K; Nakajima K; Fushiki S
Eur Neurol; 2000; 43(3):161-9. PubMed ID: 10765057
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid apolipoprotein E level is increased in late-onset Alzheimer's disease.
Merched A; Blain H; Visvikis S; Herbeth B; Jeandel C; Siest G
J Neurol Sci; 1997 Jan; 145(1):33-9. PubMed ID: 9073026
[TBL] [Abstract][Full Text] [Related]
9. APOE epsilon 3/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis.
Fukumoto H; Ingelsson M; Gårevik N; Wahlund LO; Nukina N; Yaguchi Y; Shibata M; Hyman BT; Rebeck GW; Irizarry MC
Exp Neurol; 2003 Sep; 183(1):249-53. PubMed ID: 12957508
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease.
Lehtimäki T; Pirttilä T; Mehta PD; Wisniewski HM; Frey H; Nikkari T
Hum Genet; 1995 Jan; 95(1):39-42. PubMed ID: 7814023
[TBL] [Abstract][Full Text] [Related]
11. Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels.
Bekris LM; Millard SP; Galloway NM; Vuletic S; Albers JJ; Li G; Galasko DR; DeCarli C; Farlow MR; Clark CM; Quinn JF; Kaye JA; Schellenberg GD; Tsuang D; Peskind ER; Yu CE
J Alzheimers Dis; 2008 Apr; 13(3):255-66. PubMed ID: 18430993
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E epsilon 4 allele in association with global cognitive performance and CSF markers in Alzheimer's disease.
Lasser RA; Dukoff R; Levy J; Levin R; Lehtimäki T; Seubert P; Sunderland T
Int J Geriatr Psychiatry; 1998 Nov; 13(11):767-74. PubMed ID: 9850873
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
[TBL] [Abstract][Full Text] [Related]
14. Measurement of apolipoprotein E (apoE) in cerebrospinal fluid.
Hesse C; Larsson H; Fredman P; Minthon L; Andreasen N; Davidsson P; Blennow K
Neurochem Res; 2000 Apr; 25(4):511-7. PubMed ID: 10823584
[TBL] [Abstract][Full Text] [Related]
15. Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease.
Johansson P; Almqvist EG; Bjerke M; Wallin A; Johansson JO; Andreasson U; Blennow K; Zetterberg H; Svensson J
J Alzheimers Dis; 2017; 59(3):1017-1026. PubMed ID: 28697566
[TBL] [Abstract][Full Text] [Related]
16. Reduced levels of cholesterol, phospholipids, and fatty acids in cerebrospinal fluid of Alzheimer disease patients are not related to apolipoprotein E4.
Mulder M; Ravid R; Swaab DF; de Kloet ER; Haasdijk ED; Julk J; van der Boom JJ; Havekes LM
Alzheimer Dis Assoc Disord; 1998 Sep; 12(3):198-203. PubMed ID: 9772023
[TBL] [Abstract][Full Text] [Related]
17. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K
Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606
[TBL] [Abstract][Full Text] [Related]
18. Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease.
Zimetti F; Caffarra P; Ronda N; Favari E; Adorni MP; Zanotti I; Bernini F; Barocco F; Spallazzi M; Galimberti D; Ricci C; Ruscica M; Corsini A; Ferri N
J Alzheimers Dis; 2017; 55(1):315-320. PubMed ID: 27662294
[TBL] [Abstract][Full Text] [Related]
19. The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer's disease.
Glodzik-Sobanska L; Pirraglia E; Brys M; de Santi S; Mosconi L; Rich KE; Switalski R; Saint Louis L; Sadowski MJ; Martiniuk F; Mehta P; Pratico D; Zinkowski RP; Blennow K; de Leon MJ
Neurobiol Aging; 2009 May; 30(5):672-81. PubMed ID: 17920160
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E in cerebrospinal fluid from patients with Alzheimer's disease and other forms of dementia is reduced but without any correlation to the apoE4 isoform.
Landén M; Hesse C; Fredman P; Regland B; Wallin A; Blennow K
Dementia; 1996; 7(5):273-8. PubMed ID: 8872419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
